Choreo LLC Purchases 187 Shares of Moelis & Company (NYSE:MC)

Choreo LLC lifted its position in Moelis & Company (NYSE:MC) by 4.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,831 shares of the asset manager’s stock after purchasing an additional 187 shares during the quarter. Choreo LLC’s holdings in Moelis & Company were worth $358,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in MC. Reston Wealth Management LLC purchased a new position in Moelis & Company in the third quarter worth $26,000. R Squared Ltd purchased a new position in Moelis & Company in the fourth quarter worth $47,000. GAMMA Investing LLC grew its position in Moelis & Company by 115.8% in the third quarter. GAMMA Investing LLC now owns 995 shares of the asset manager’s stock worth $68,000 after acquiring an additional 534 shares in the last quarter. Blue Trust Inc. boosted its position in Moelis & Company by 193.0% during the third quarter. Blue Trust Inc. now owns 1,081 shares of the asset manager’s stock valued at $74,000 after buying an additional 712 shares during the period. Finally, Whittier Trust Co. of Nevada Inc. purchased a new stake in Moelis & Company during the third quarter valued at about $75,000. Institutional investors own 91.53% of the company’s stock.

Moelis & Company Price Performance

Shares of Moelis & Company stock opened at $76.03 on Thursday. The stock has a market capitalization of $5.70 billion, a PE ratio of 43.20 and a beta of 1.40. Moelis & Company has a 1-year low of $46.24 and a 1-year high of $82.89. The company’s fifty day simple moving average is $75.65 and its 200-day simple moving average is $71.13.

Moelis & Company (NYSE:MC) last announced its quarterly earnings data on Wednesday, February 5th. The asset manager reported $1.18 EPS for the quarter, beating the consensus estimate of $0.39 by $0.79. Moelis & Company had a net margin of 11.39% and a return on equity of 38.49%. As a group, research analysts anticipate that Moelis & Company will post 2.57 EPS for the current year.

Moelis & Company Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 27th. Shareholders of record on Tuesday, February 18th will be paid a $0.65 dividend. This is a boost from Moelis & Company’s previous quarterly dividend of $0.60. This represents a $2.60 dividend on an annualized basis and a dividend yield of 3.42%. The ex-dividend date is Tuesday, February 18th. Moelis & Company’s dividend payout ratio (DPR) is presently 136.36%.

Analyst Upgrades and Downgrades

MC has been the subject of several analyst reports. Morgan Stanley upped their price target on shares of Moelis & Company from $95.00 to $100.00 and gave the company an “overweight” rating in a research report on Thursday, February 6th. The Goldman Sachs Group upped their price target on shares of Moelis & Company from $79.00 to $87.00 and gave the company a “neutral” rating in a research report on Thursday, February 6th. Keefe, Bruyette & Woods reaffirmed an “outperform” rating and set a $92.00 price objective (up from $86.00) on shares of Moelis & Company in a research note on Thursday, February 6th. Wells Fargo & Company upped their price objective on shares of Moelis & Company from $77.00 to $83.00 and gave the company an “equal weight” rating in a research note on Thursday, February 6th. Finally, JMP Securities reaffirmed a “market perform” rating on shares of Moelis & Company in a research note on Thursday, February 6th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, Moelis & Company has a consensus rating of “Hold” and an average price target of $78.83.

Moelis & Company Company Profile

Moelis & Company operates as an investment banking advisory firm. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic, capital structure, and private funds advisory.